Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BXL628 in women with detrusor overactivity (Phase IIb)
2007-001214-16Phase 2Completed
- Sponsor
- Bioxell GmbH
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in overactive bladder (OAB) and cystospasm comparing BXL628 with Placebo (2 arms). Primary endpoint: Change in bladder volume at first involuntary contraction. Started Jun 2007; status: completed.
02
Drugs
elocalcitol
03
Conditions
overactive bladder (OAB)cystospasm
Beyond the preview
Go deeper on 2007-001214-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001214-16.